BACKGROUND: Markers of protein-energy wasting (PEW) and inflammation are common in chronic kidney disease (CKD) and are among the strongest predictors of mortality in dialysis patients. OBJECTIVE: We hypothesized that markers of PEW and inflammation show similar associations in patients with non-dialysis-dependent CKD (NDD-CKD). DESIGN: We examined the associations of serum albumin, white blood cell (WBC) count, percentage of lymphocytes in WBCs (%LYM), and a combination of all 3 with all-cause mortality and with the composite of predialysis mortality or end-stage renal disease (ESRD) by using fixed-covariate and time-dependent Cox models in 1220 men with NDD-CKD. RESULTS: Lower albumin and %LYM and a higher WBC count were significantly associated with outcomes. In time-dependent Cox models, compared with patients in whom none of these markers indicated PEW, those in whom 1, 2, or all 3 markers indicated the presence of PEW had multivariable-adjusted hazard ratios (95% CI) for all-cause mortality of 1.7 (1.2, 2.4), 2.4 (1.7, 3.4), and 3.6 (2.5, 5.1); the P for trend was <0.001. Similar associations were present in fixed-covariate models for all-cause mortality and in fixed-covariate and time-dependent models for the composite outcome. CONCLUSIONS: Traditional and nontraditional markers of PEW display robust, strong, and independent associations with mortality in patients with NDD-CKD. Clinical trials are warranted to examine whether PEW-improving interventions can lead to better outcomes in these patients.
BACKGROUND: Markers of protein-energy wasting (PEW) and inflammation are common in chronic kidney disease (CKD) and are among the strongest predictors of mortality in dialysis patients. OBJECTIVE: We hypothesized that markers of PEW and inflammation show similar associations in patients with non-dialysis-dependent CKD (NDD-CKD). DESIGN: We examined the associations of serum albumin, white blood cell (WBC) count, percentage of lymphocytes in WBCs (%LYM), and a combination of all 3 with all-cause mortality and with the composite of predialysis mortality or end-stage renal disease (ESRD) by using fixed-covariate and time-dependent Cox models in 1220 men with NDD-CKD. RESULTS: Lower albumin and %LYM and a higher WBC count were significantly associated with outcomes. In time-dependent Cox models, compared with patients in whom none of these markers indicated PEW, those in whom 1, 2, or all 3 markers indicated the presence of PEW had multivariable-adjusted hazard ratios (95% CI) for all-cause mortality of 1.7 (1.2, 2.4), 2.4 (1.7, 3.4), and 3.6 (2.5, 5.1); the P for trend was <0.001. Similar associations were present in fixed-covariate models for all-cause mortality and in fixed-covariate and time-dependent models for the composite outcome. CONCLUSIONS: Traditional and nontraditional markers of PEW display robust, strong, and independent associations with mortality in patients with NDD-CKD. Clinical trials are warranted to examine whether PEW-improving interventions can lead to better outcomes in these patients.
Authors: Kamyar Kalantar-Zadeh; Gladys Block; Charles J McAllister; Michael H Humphreys; Joel D Kopple Journal: Am J Clin Nutr Date: 2004-08 Impact factor: 7.045
Authors: Donal N Reddan; Preston S Klassen; Lynda A Szczech; Joseph A Coladonato; Susan O'Shea; William F Owen; Edmund G Lowrie Journal: Nephrol Dial Transplant Date: 2003-06 Impact factor: 5.992
Authors: Atul J Butte; Tara K Sigdel; Persis P Wadia; David B Miklos; Minnie M Sarwal Journal: Mol Cell Proteomics Date: 2010-12-23 Impact factor: 5.911
Authors: Lynn M Taylor; Kamyar Kalantar-Zadeh; Theodore Markewich; Sara Colman; Debbie Benner; John J Sim; Csaba P Kovesdy Journal: J Ren Care Date: 2011-03
Authors: Miklos Z Molnar; Juan J Carrero; Istvan Mucsi; Adam Remport; Connie M Rhee; Kamyar Kalantar-Zadeh; Csaba P Kovesdy; Antonio C Cordeiro Journal: Int Urol Nephrol Date: 2015-05-01 Impact factor: 2.370
Authors: Miklos Z Molnar; Elani Streja; Csaba P Kovesdy; Matthew J Budoff; Allen R Nissenson; Mahesh Krishnan; Stefan D Anker; Keith C Norris; Gregg C Fonarow; Kamyar Kalantar-Zadeh Journal: Am J Clin Nutr Date: 2011-08-03 Impact factor: 7.045
Authors: Nazanin Noori; Csaba P Kovesdy; Ramanath Dukkipati; Usama Feroze; Miklos Z Molnar; Rachelle Bross; Allen R Nissenson; Joel D Kopple; Keith C Norris; Kamyar Kalantar-Zadeh Journal: Am J Nephrol Date: 2011-02-04 Impact factor: 3.754
Authors: Rasheed A Balogun; Emaad M Abdel-Rahman; Seki A Balogun; Evan H Lott; Jun Ling Lu; Sandra M Malakauskas; Jennie Z Ma; Kamyar Kalantar-Zadeh; Csaba P Kovesdy Journal: Clin J Am Soc Nephrol Date: 2012-08-16 Impact factor: 8.237